New generations of synthetic biomaterials are being developed at a rapid pace for use as three-dimensional extracellular microenvironments to mimic the regulatory characteristics of natural extracellular matrices (ECMs) and ECM-bound growth factors, both for therapeutic applications and basic biological studies. Recent advances include nanofibrillar networks formed by self-assembly of small building blocks, artificial ECM networks from protein polymers or peptide-conjugated synthetic polymers that present bioactive ligands and respond to cell-secreted signals to enable proteolytic remodeling. These materials have already found application in differentiating stem cells into neurons, repairing bone and inducing angiogenesis. Although modern synthetic biomaterials represent oversimplified mimics of natural ECMs lacking the essential natural temporal and spatial complexity, a growing symbiosis of materials engineering and cell biology may ultimately result in synthetic materials that contain the necessary signals to recapitulate developmental processes in tissue– and organ-specific differentiation and morphogenesis.
Nat Biotechnol. 2005 Jan;23(1):47-55.
Lutolf MP, Hubbell JA.
The Scientist, February 22, 2018
Nature Medicine. Sept 2017; Vol 23, Nr 9: 1028-1035
Cell. 2018 Jan 11;172(1-2):373-386.
Trends Mol Med. 2017 May;23(5):393-410.
Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):E6831-E6839.
Nature. 2016 Nov 24;539(7630):560-564.
Subscribe to our newsletter
Stay up-to-date on the latest advancements in 3D cell culture technology